Picture of Protalix BioTherapeutics logo

PLX — Protalix BioTherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Eyal Rubin Resigns As CFO Of Protalix Biotherapeutics - SEC Filing

April 23 (Reuters) - Protalix Biotherapeutics Inc PBDA.F:

PROTALIX BIOTHERAPEUTICS INC - ON APRIL 21 EYAL RUBIN RESIGNS AS CFO OF PROTALIX BIOTHERAPEUTICS - SEC FILING

Source text: [ID:n0001558370-25-005275]

Further company coverage: PBDA.F

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Protalix BioTherapeutics

See all news